Stock Market News
ECO Animal Health gets regulatory go-ahead in Argentina
ECO Animal Health Group announced on Monday that its subsidiary, ECO Argentina, has received a number of marketing authorisations for 'Aivlosin' from Servicio Nacional de Sanidad y Calidad Agroalimentaria (SENASA) in the Republic of Argentina.
The AIM-traded firm said its patented antimicrobial Aivlosin is used for the treatment of a variety of economically important respiratory and enteric diseases in pigs and poultry.
It said the authorisations, which were for the use of Aivlosin 625 mg/g water soluble granules for both pigs and poultry, would allow ECO to start selling Aivlosin in Argentina for the medication of drinking water for the treatment of infections caused by mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.
The new treatments met all the latest guidelines for the responsible use of antimicrobials, the board claimed.
It added that, with global concerns about the use of antibiotics in food production animals, Aivlosin was administered under the control of veterinarians, available by prescription only and had low, highly effective therapeutic dose rates, a short treatment duration and a zero day drug withholding period.
"We are extremely pleased to receive these marketing authorisations for Aivlosin in Argentina, the third largest egg and second largest pork producing country in South America," commented ECO Animal Health chairman Peter Lawrence.
The AIM-traded firm said its patented antimicrobial Aivlosin is used for the treatment of a variety of economically important respiratory and enteric diseases in pigs and poultry.
It said the authorisations, which were for the use of Aivlosin 625 mg/g water soluble granules for both pigs and poultry, would allow ECO to start selling Aivlosin in Argentina for the medication of drinking water for the treatment of infections caused by mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.
The new treatments met all the latest guidelines for the responsible use of antimicrobials, the board claimed.
It added that, with global concerns about the use of antibiotics in food production animals, Aivlosin was administered under the control of veterinarians, available by prescription only and had low, highly effective therapeutic dose rates, a short treatment duration and a zero day drug withholding period.
"We are extremely pleased to receive these marketing authorisations for Aivlosin in Argentina, the third largest egg and second largest pork producing country in South America," commented ECO Animal Health chairman Peter Lawrence.
Related share prices |
---|
ECO Animal Health Group (EAH) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price